« Previous article
New RT-PCR Kit Detec...

1st April 2021  Product update: rapidmicrobiology staff writer

New B. burgdorferi  (Lyme Disease) Serological Assay Available 

Gold Standard Diagnostics (GSD) has launched a new Lyme Disease serologic assay, the B. burgdorferi IgG/IgM VlsE-OspC ELISA.

This assay has been FDA cleared for use as an integral part of the Modified Two-Tiered Testing algorithm (MTTT) available from GSD.

"Using the B. burgdorferi IgG/IgM VlsE-OspC test in combination with a second GSD Lyme EIA, we maintain >98% specificity while demonstrating a nearly 20% increase in early Lyme disease detection compared with the Standard Two-Tiered Testing algorithm (STTT)", said GSD in a press release.

Gold Standard Diagnostics is the only company offering kits in the U.S. to fulfill Lyme testing requirements for both the Standard and Modified two-tiered testing algorithms. Their four EIA kits and two Immunoblot kits allow flexibility for a lab to meet their clients’ needs. 


Image: Modified Two-Tiered Testing Algorithm (Credit: GSD)

If you want further details about this product, please use the 'Request Information' button below.

Share on:


Date Published: 1st April 2021

Source article link: View

Note: This content has been edited by a rapidmicrobiology staff writer for style and content.

View full company details

Gold Standard Diagnostics



Tel: +49 160 967 399 98

Email Supplier

View full company details

Related news from Gold Standard Diagnostics